High-Sensitivity Troponin Implementation
General Information
Munson Healthcare will be transitioning to a new cardiac troponin assay in 2022. The High-Sensitivity Troponin (hs-TnI) assay will be replacing our current Troponin lab series beginning April 12, 2022.
Most patients presenting to an Emergency Department with a chief complaint of chest pain are not actually having an acute coronary syndrome event. The hs-TnI lab assay allows faster, more accurate information about cardiac injury, facilitating quicker intervention for those who are high risk and actually experiencing a cardiac event and quicker rule-out and discharge for low risk patients.
Click here for more information about why this implementation will be great for our patients.
Click here to download a PPT that can be shared with your colleagues
Treatment Algorithm
Scan the QR code below for the hs-Tnl Treatment Algorithm
Educational Resources
On-Demand CME
- Recorded Lecture: Transition to High Sensitivity Troponin Testing Across the MHC System: What you need to know: Click here
- Self-directed CME Activity: High Sensitivity Troponin: Overview and Case Studies: Click here
Reference Information
- JACC Article: Latest in ED Risk Stratification of Chest Pain: hs-cTn and Risk Scores
-
Circulation Article: High-Sensitivity Cardiac Troponin: A Stepped-Wedge Cluster RCT
-
Circulation Article: Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the ED